Samsung Biologics to Purchase Land for Second Bio Campus

Plans to build multi-modal plant and open innovation facility with expanded manufacturing capacities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Samsung Biologics, a contract development and manufacturing organization (CDMO), has signed a land purchase agreement with the Incheon Free Economic Zone (IFEZ) on to support the build out of its second Bio Campus. The additionally acquired land is located within Songdo Industrial Cluster, covering an area of 357,366 square meters which is 30% larger than the company’s current campus. Bio Campus II is designed to support Samsung Biologics’ further expansion of large-scale manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters